联系我们 加入收藏
 
年期检索 高级检索
33
2025年8月15日 星期五
农业生物技术学报  2022, Vol. 30 Issue (6): 1219-1227    DOI: 10.3969/j.issn.1674-7968.2022.06.017
  研究资源与技术改进 本期目录 | 过刊浏览 | 高级检索 |
基于猪口蹄疫O型病毒结构蛋白VP1基因的mRNA疫苗制备及免疫活性研究
董金杰1,2,3,4, 王会宝2, 王凡2, 邓瑞雪2, 刘萍2, 陈苗苗2, 李扬帆2, 张勇1,4,*
1 甘肃农业大学 动物医学院,兰州 730070;
2 中农威特生物科技股份有限公司,兰州 730046;
3 中国农业科学院 兰州兽医研究所,兰州730046;
4 甘肃省动物生理学和生殖调控重点实验室
Preparation and Immunogenicity Studies on mRNA Vaccine Based on VP1 Gene of Porcine foot-and-mouth disease type O virus
DONG Jin-Jie1,2,3,4, WANG Hui-Bao2, WANG Fan2, DENG Rui-Xue2, LIU Ping2, CHEN Miao-Miao2, LI Yang-Fan2, ZHANG Yong1,4,*
1 College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China;
2 China Agricultural Vet. Bio. Science and Technology Co., Ltd., Lanzhou 730046, China;
3 Lanzhou Veterinary Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China;
4 Gansu Key Laboratory of Animal Generational Physiology and Reproductive Regulation
全文: PDF (4570 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 口蹄疫(Foot-and-mouth disease, FMD)是危害养猪(Sus scrofa domesticus)业最重要的传染病之一,疫苗免疫是防控口蹄疫的重要手段之一。由于口蹄疫病毒(Foot-and-mouth disease virus, FMDV)容易发生变异,致使候选疫苗株和流行毒株间的抗原不匹配,从而影响疫苗免疫效力和疫病预防效果。本研究根据结构蛋白VP1 (viral structural protein 1)基因序列和功能,以猪口蹄疫病毒O型毒株(O/MYA98/BY/2010株)灭活抗原为模板,扩增结构蛋白VP1基因,并与pSFV1载体连接构建重组质粒pSFV1-VP1。重组质粒经线性化、体外转录等方法处理获得的mRNA,转染BHK-21细胞并验证表达效果,然后与制备的脂质体纳米颗粒混合免疫豚鼠(Cavia porcellus),进行免疫应答水平和攻毒保护效果检测。结果表明,mRNA转染乳仓鼠肾(baby hamster syrian kidney-21, BHK-21)细胞24 h后,采用免疫荧光法(immunofluorescence assay, IFA)和Western blot法均证实VP1得到表达;mRNA疫苗免疫豚鼠后血清中特异性抗体、中和抗体、γ干扰素(γ interferon, IFN-γ)和白介素4 (interleukin 4, IL-4)均显著高于阴性对照组。试制的mRNA疫苗免疫豚鼠可以对50倍50%豚鼠感染量(50% guinea pig infectious dose, GPID50)的O/MYA98/BY/2010株攻击提供4/4保护。以上结果表明,试制的mRNA疫苗可以诱导较强的体液免疫与细胞免疫应答,免疫原性良好。本研究为研制口蹄疫紧急预防接种疫苗提供了新途径。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
董金杰
王会宝
王凡
邓瑞雪
刘萍
陈苗苗
李扬帆
张勇
关键词 口蹄疫病毒结构蛋白VP1 (VP1)mRNA疫苗免疫原性    
Abstract:Foot-and-mouth disease (FMD) is one of the most important infectious diseases causing significant economic losses to the swine (Sus scrofa domesticus) industry. Vaccine immunization is still the one of main ways to prevent and control foot-and-mouth disease. Because Foot-and-mouth disease virus is easy to mutate, the antigen mismatch between candidate vaccine strains and epidemic strains will affect the immune efficacy of vaccine and the effect of disease control. According to the molecular and functional characteristics of structural protein VP1 (viral structural protein) gene, using the inactivated Porcine foot-and-mouth disease virus type O strain (O /MYA98/BY/2010) as the template, the structural protein VP1 gene was amplified and ligated into pSFV1 vector to construct the recombinant plasmid pSFV1-VP1. To obtain mRNA, the recombinant plasmid was treated by linearization and in vitro transcription, then the mRNA was transfected into baby hamster syrian kidney-21 (BHK-21) cells and verified its expression properly. After that, it was mixed with the liposome nanoparticles to immunize guinea pigs (Cavia porcellus), and the immune response and efficacy were detected. The results showed that the mRNA was expressed in BHK-21 cells after 24 h post-transfection evaluated by immunofluorescence assay (IFA) and Western blot; In guinea pigs immunized with the mRNA vaccine, specific antibody, neutralizing antibody, interleukin 4 (IL-4) and γ interferon (IFN-γ) in serum were significantly higher than those of guinea pigs. The mRNA vaccine could provide 4/4 protection against 50 times GPID50 (50% Guinea pig infectious dose) virus challenge in vaccinated guinea pigs, implying humoral and cellular immune response elicited by the developed mRNA vaccine with sound immunogenicity, which provides a new route for the development of foot-and-mouth disease emergency vaccine.
Key wordsFoot-and-mouth disease virus (FMDV)    Viral structural protein 1 (VP1)    mRNA vaccine    Immunogenicity
收稿日期: 2021-11-16     
ZTFLH:  S855.3  
基金资助:甘肃省青年科技基金计划(20JR10RA475); 甘肃省动物生理学和生殖调控重点实验室(20JR10RA563)
通讯作者: * zhychy@163.com   
引用本文:   
董金杰, 王会宝, 王凡, 邓瑞雪, 刘萍, 陈苗苗, 李扬帆, 张勇. 基于猪口蹄疫O型病毒结构蛋白VP1基因的mRNA疫苗制备及免疫活性研究[J]. 农业生物技术学报, 2022, 30(6): 1219-1227.
DONG Jin-Jie, WANG Hui-Bao, WANG Fan, DENG Rui-Xue, LIU Ping, CHEN Miao-Miao, LI Yang-Fan, ZHANG Yong. Preparation and Immunogenicity Studies on mRNA Vaccine Based on VP1 Gene of Porcine foot-and-mouth disease type O virus. 农业生物技术学报, 2022, 30(6): 1219-1227.
链接本文:  
http://journal05.magtech.org.cn/Jwk_ny/CN/10.3969/j.issn.1674-7968.2022.06.017     或     http://journal05.magtech.org.cn/Jwk_ny/CN/Y2022/V30/I6/1219
 
版权所有 © 2014 《农业生物技术学报》编辑部   京ICP备11035905号-3
地址:北京市海淀区圆明园西路2号中国农业大学生命科学楼1053室 邮编:100193
电话:010-62733684 传真:010-62731615 E-mail: nsjxb@cau.edu.cn